Amphastar Pharmaceuticals is a biopharmaceutical company focused on developing, manufacturing, and commercializing technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as active pharmaceutical ingredients. Key products include BAQSIMI glucagon nasal powder, Primatene MIST, glucagon, epinephrine, and lidocaine. For 2025, the company recorded net revenues of $719.9 million and net income of $98.1 million.
Q2 FY2026 — expected 2026-09-15
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001297184-26-000009 | EDGAR | 102K words |
| 2025-03-03 | 2024-12-31 | 0001297184-25-000008 | EDGAR | 101K words |
| 2024-02-29 | 2023-12-31 | 0001297184-24-000009 | EDGAR | 107K words |
| 2023-03-01 | 2022-12-31 | 0001297184-23-000019 | EDGAR | 99K words |
| 2022-03-11 | 2021-12-31 | 0001297184-22-000007 | EDGAR | — |
| 2021-03-15 | 2020-12-31 | 0001297184-21-000008 | EDGAR | — |
| 2020-03-16 | 2019-12-31 | 0001297184-20-000007 | EDGAR | — |
| 2019-03-15 | 2018-12-31 | 0001297184-19-000013 | EDGAR | — |
| 2018-03-14 | 2017-12-31 | 0001297184-18-000011 | EDGAR | — |
| 2017-03-15 | 2016-12-31 | 0001297184-17-000007 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-06 | 2026-06-30 | 0001297184-26-000047 | EDGAR | 31K words |
| 2025-11-06 | 2025-09-30 | 0001297184-25-000064 | EDGAR | 33K words |
| 2025-08-07 | 2025-06-30 | 0001297184-25-000050 | EDGAR | 32K words |
| 2025-05-08 | 2025-03-31 | 0001297184-25-000029 | EDGAR | 25K words |
| 2024-11-07 | 2024-09-30 | 0001297184-24-000058 | EDGAR | 33K words |
| 2024-08-09 | 2024-06-30 | 0001297184-24-000048 | EDGAR | 32K words |
| 2024-05-10 | 2024-03-31 | 0001297184-24-000037 | EDGAR | 27K words |
| 2023-11-08 | 2023-09-30 | 0001297184-23-000082 | EDGAR | 40K words |
| 2023-08-09 | 2023-06-30 | 0001297184-23-000066 | EDGAR | 37K words |
| 2023-05-09 | 2023-03-31 | 0001297184-23-000049 | EDGAR | 30K words |
| 2022-11-08 | 2022-09-30 | 0001297184-22-000056 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0001297184-22-000044 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-06 | 0001297184-26-000045 | EDGAR | 6K words |
| 2026-07-13 | 0001104659-26-082772 | EDGAR | 1K words |
| 2026-03-16 | 0001104659-26-027814 | EDGAR | 1K words |
| 2026-03-06 | 0001297184-26-000015 | EDGAR | 14K words |
| 2026-03-06 | 0001297184-26-000013 | EDGAR | 6K words |
| 2026-02-26 | 0001297184-26-000007 | EDGAR | 7K words |
| 2026-01-12 | 0001297184-26-000002 | EDGAR | 1K words |
| 2025-11-06 | 0001297184-25-000062 | EDGAR | 6K words |
| 2025-10-24 | 0001297184-25-000058 | EDGAR | 1K words |
| 2025-09-18 | 0001297184-25-000054 | EDGAR | 1K words |
176 total filings indexed. 144 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001297184 |
| Ticker | AMPH |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Website | https://www.amphastar.com |
| Listed | 2014-06-25 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/AMPH (~200 tokens, structured JSON with cryptographic provenance)